throbber
Case IPR2016-00318
`Patent 7,772,209
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`SANDOZ INC.,
`Petitioner,
`
`v .
`
`ELI LILLY AND COMPANY,
`Patent Owner.
`
`Case IPR2016-00318
`Patent 7,772,209
`
`PETITIONER SANDOZ INC.’S
`UPDATED MANDATORY NOTICES
`PURSUANT TO 37 C.F.R. § 42.8
`
`

`
`Case IPR2016-00318
`Patent 7,772,209
`
`A. Real Party-In-Interest (UNCHANGED)
`
`Sandoz Inc. is the real party-in-interest for the instant petition.
`
`B. Related Matters (UPDATED)
`
`1. Related Litigations
`
`Petitioner is not aware of any reexamination certificates or pending
`
`prosecution concerning the ’209 patent. Petitioner is a defendant in the following
`
`litigation involving the ’209 patent: Eli Lilly & Co. v. Sandoz Inc., No. 1:14-cv-
`
`2008 (S.D. Ind., filed December 5, 2014) (“Sandoz Litigation”). Sandoz has timely
`
`filed this petition pursuant to 35 U.S.C. § 315(b) within one year of the date “on
`
`which the petitioner . . . [was] served with [the] complaint alleging infringement of
`
`the patent” – December 15, 2014. Ex. 1053, Return of Service. The Patent Owner
`
`has also asserted the ’209 patent in the following additional litigations in which
`
`Petitioner was not and is not a party: Eli Lilly & Co. v. Teva Parenteral Medicines,
`
`Inc., No. 1:10-cv-1376 (S.D. Ind., filed October 29, 2010) (“Teva Litigation”); Eli
`
`Lilly & Co. v. APP Pharmaceuticals, LLC, No. 1:11-cv-942 (S.D. Ind., filed July
`
`15, 2011); Eli Lilly & Co. v. Accord Healthcare, Inc., USA, No. 1:12-cv-86 (S.D.
`
`Ind., filed January 20, 2012); Eli Lilly & Co. v. Apotex Inc., No. 1:12-cv-499 (S.D.
`
`Ind., filed April 17, 2012); Eli Lilly & Co. v. Accord Healthcare Inc., USA, No.
`
`1:13-cv-335 (S.D. Ind., filed February 28, 2013); Eli Lilly & Co. v. Sun
`
`Pharmaceutical Industries Ltd., No. 1:13-cv-1469 (S.D. Ind., filed September 13,
`
`2
`
`

`
`Case IPR2016-00318
`Patent 7,772,209
`2013); Eli Lilly & Co. v. Glenmark Generics Inc., USA, No. 1:14-cv-104 (S.D.
`
`Ind., filed January 23, 2014); Eli Lilly & Co. v. Nang Kuang Pharmaceutical Co.,
`
`Ltd., No. 1:14-cv-1647 (S.D. Ind., filed October 8, 2014); Eli Lilly & Co. v.
`
`Fresenius Kabi USA, LLC, No. 1:15-cv-96 (S.D. Ind., filed January 23, 2015); Eli
`
`Lilly & Co. v. Mylan Laboratories Ltd., No. 1:15-cv-1083 (S.D. Ind., filed July 10,
`
`2015); Eli Lilly & Co. v. Emcure Pharmaceuticals Ltd., No. 1:15-cv-1244 (S.D.
`
`Ind., filed August 7, 2015); and Eli Lilly & Co. v. Dr. Reddy’s Laboratories, Ltd. et
`
`al., No. 1:16-cv-308 (S.D. Ind., filed Feb. 5, 2016).
`
`Petitioner newly identifies the following additional litigation in which the
`
`Patent Owner has asserted the ’209 patent and in which Petitioner was not and is
`
`not a party: Eli Lilly & Co. v. Biocon Ltd., No. 1:16-cv-469 (S.D. Ind., filed Feb.
`
`26, 2016).
`
`2. Related Proceedings Before the Board
`
`The ’209 patent has also been challenged before the Board in the following
`
`proceedings in which Petitioner was not and is not a party: Accord Healthcare,
`
`Inc., USA v. Eli Lilly & Co., IPR2013-356 (PTAB, filed June 14, 2013); Neptune
`
`Generics, LLC v. Eli Lilly & Co., IPR2016-237 (PTAB, filed November 24, 2015);
`
`and Neptune Generics, LLC v. Eli Lilly & Co., IPR2016-240 (PTAB, filed
`
`November 24, 2015). On October 1, 2013, the Board denied institution of Accord
`
`Healthcare Inc.’s petition in IPR2013-356 because the petition was not filed within
`
`3
`
`

`
`Case IPR2016-00318
`Patent 7,772,209
`the time limit imposed by 35 U.S.C. § 315(b). Neptune Generics, LLC’s
`
`(“Neptune”) two petitions are pending before the Board.
`
`Petitioner newly identifies the following additional proceedings before the
`
`Board in which the ’209 patent has been challenged and in which Petitioner was
`
`not and is not a party: Wockhardt Bio AG v. Eli Lilly & Co., IPR2016-1335
`
`(PTAB, filed June 30, 2016); Wockhardt Bio AG v. Eli Lilly & Co., IPR2016-1337
`
`(PTAB, filed June 30, 2016); Wockhardt Bio AG v. Eli Lilly & Co., IPR2016-1393
`
`(PTAB, filed July 8, 2016); Apotex Inc. & Apotex Corp. v. Eli Lilly & Co.,
`
`IPR2016-1190 (PTAB, filed July 1, 2016); Apotex Inc. & Apotex Corp. v. Eli Lilly
`
`& Co., IPR2016-1191 (PTAB, filed July 1, 2016); Apotex Inc. et al. v. Eli Lilly &
`
`Co., IPR2016-1429 (PTAB, filed July 14, 2016); Teva Pharm. USA, Inc. &
`
`Fresenius Kabi USA, LLC v. Eli Lilly & Co., IPR2016-1340 (PTAB, filed July 1,
`
`2016); Teva Pharm. USA, Inc. & Fresenius Kabi USA, LLC v. Eli Lilly & Co.,
`
`IPR2016-1341 (PTAB, filed July 1, 2016); and Teva Pharm. USA, Inc. &
`
`Fresenius Kabi USA, LLC v. Eli Lilly & Co., IPR2016-1343 (PTAB, filed July 1,
`
`2016). The Petitioners in IPR2016-1335, IPR2016-1190, and IPR2016-1341
`
`requested joinder with IPR2016-237. The Petitioners in IPR2016-1337, IPR2016-
`
`1191, and IPR2016-1343 requested joinder with IPR2016-240. The Petitioners in
`
`IPR2016-1340, IPR2016-1393, and IPR2016-1429 requested joinder with the
`
`instant proceeding.
`
`4
`
`

`
`Case IPR2016-00318
`Patent 7,772,209
`
`C. Lead and Back-Up Counsel (UPDATED)
`
`Lead Counsel
`Ralph J. Gabric (Reg. No. 34,167)
`rgabric@brinksgilson.com
`Brinks Gilson & Lione
`Suite 3600 NBC Tower
`455 Cityfront Plaza Drive
`Chicago IL 60611-5599
`T: 312-321-4200, F: 312-321-4299
`
`Back-Up Counsel
`Laura Lydigsen
`(pro hac vice motion to be filed)
`llydigsen@brinksgilson.com
`Brinks Gilson & Lione
`Suite 3600 NBC Tower
`455 Cityfront Plaza Drive
`Chicago IL 60611-5599
`T: 312-321-4200, F: 312-321-4299
`
`Bryan T. Richardson, Ph.D. (Reg. No.
`70,572)
`brichardson@brinksgilson.com
`Brinks Gilson & Lione
`4721 Emperor Boulevard
`Suite 220
`Durham, NC 27703-8580
`T: 919-998-5700, F: 919-998-5701
`
`Joshua H. James (Reg. No. 72,568)
`jjames@brinksgilson.com
`Postal and Hand-Delivery Address:
`Brinks Gilson & Lione
`Suite 3600 NBC Tower
`455 Cityfront Plaza Drive
`Chicago IL 60611-5599
`T: 312-321-4200, F: 312-321-4299
`
`D. Service Information (UNCHANGED)
`
`Please address all correspondence to the lead and backup counsel at the
`
`contact information above. Petitioner also consents to service by email at
`
`rgabric@brinksgilson.com and llydigsen@brinksgilson.com.
`
`5
`
`

`
`Dated: July 20, 2016
`
`Case IPR2016-00318
`Patent 7,772,209
`Respectfully submitted,
`
`/s/ Ralph J. Gabric
`Ralph J. Gabric (Reg. No. 34,167)
`Laura L. Lydigsen
`Bryan T. Richardson, Ph.D. (Reg. No.
`70,572)
`Joshua H. James (Reg. No. 72,568)
`Brinks Gilson & Lione
`NBC Tower – Suite 3600
`455 N. Cityfront Plaza Dr.
`Chicago, Illinois 60611
`
`6
`
`

`
`CERTIFICATE OF SERVICE
`
`Case IPR2016-00318
`Patent 7,772,209
`
`I hereby certify that true and correct copies of the foregoing Petitioner Sandoz
`Inc.’s Updated Mandatory Notices Under 37 C.F.R. § 42.8 were served on July 20,
`2016 via electronic mail to the following individuals at the email addresses below.
`
`Dov P. Grossman (Reg. No. 72,525)
`Williams & Connolly LLP
`725 Twelfth St. NW
`Washington DC 20005
`Direct Phone: 202-434-5812
`Facsimile: 202-434-5029
`dgrossman@wc.com
`
`David M. Krinsky (Reg. No. 72,339)
`Williams & Connolly LLP
`725 Twelfth St. NW
`Washington DC 20005
`Direct Phone: 202-434-5338
`Facsimile: 202-480-8302
`dkrinsky@wc.com
`
`Adam L. Perlman
`Williams & Connolly LLP
`725 Twelfth St. NW
`Washington DC 20005
`Direct Phone: 202-434-5244
`aperlman@wc.com
`
`James P. Leeds (Reg. No. 35,241)
`Eli Lilly and Company
`Lilly Corporate Center
`Indianapolis, IN 46285
`Direct Phone: 317-276-1667
`Facsimile: 317-277-6534
`leeds_james@lilly.com
`
`

`
`Dated: July 20, 2016
`
`Case IPR2016-00318
`Patent 7,772,209
`
`/s/ Ralph J. Gabric
`Ralph J. Gabric (Reg. No. 34,167)
`Laura L. Lydigsen
`Bryan T. Richardson, Ph.D. (Reg. No.
`70,572)
`Joshua H. James (Reg. No. 72,568)
`Brinks Gilson & Lione
`NBC Tower – Suite 3600
`455 N. Cityfront Plaza Dr.
`Chicago, Illinois 60611

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket